Melanoma of Unknown Primary
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06186 | Ipilimumab | 1 | Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
| DB11967 | Binimetinib | 2 | Active Not Recruiting | 1 |
| DB19293 | CDX-301 | 2 | Completed | 1 |
| DB19291 | Cancer/testis antigen 1 | 2 | Completed | 1 |
| DB11059 | Carboxymethylcellulose | 2 | Completed | 1 |
| DB11718 | Encorafenib | 2 | Active Not Recruiting | 1 |
| DB17293 | Hiltonol | 2 | Completed | 1 |
| DB06186 | Ipilimumab | 2 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Recruiting | 1 |
| DB00123 | Lysine | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Suspended | 1 |
| DB15185 | Rasdegafusp alfa | 2 | Completed | 1 |
| DB17500 | Vidutolimod | 2 | Suspended | 1 |
| DB11105 | Benzalkonium | 3 | Active Not Recruiting | 1 |
| DB05258 | Interferon alfa | 3 | Active Not Recruiting | 1 |
| DB00105 | Interferon alfa-2b | 3 | Active Not Recruiting | 1 |
| DB06186 | Ipilimumab | 3 | Active Not Recruiting | 1 |